The analytical specificity of the VIDAS® anti-CHIKV IgM and IgG assays was evaluated using samples from patients with other proven infections and who had tested positive for the respective pathogen-specific IgM, IgG, or total antibodies, and tested negative with the respective competitor ELISA. This evidence concerns the gene CD40LG and infection.